Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 40
Filter
2.
Mediators Inflamm ; 2016: 7368389, 2016.
Article in English | MEDLINE | ID: mdl-26949291

ABSTRACT

We hypothesize that melanocortin receptors (MC) could activate tissue protective circuit in a model of streptozotocin- (STZ-) induced diabetic retinopathy (DR) in mice. At 12-16 weeks after diabetes induction, fluorescein angiography (FAG) revealed an approximate incidence of 80% microvascular changes, typical of DR, in the animals, without signs of vascular leakage. Occludin progressively decreased in the retina of mice developing retinopathy. qPCR of murine retina revealed expression of two MC receptors, Mc1r and Mc5r. The intravitreal injection (5 µL) of the selective MC1 small molecule agonist BMS-470539 (33 µmol) and the MC5 peptidomimetic agonist PG-901 (7.32 nM) elicited significant protection with regular course and caliber of retinal vessels, as quantified at weeks 12 and 16 after diabetes induction. Mouse retina homogenate settings indicated an augmented release of IL-1α, IL-1ß, IL-6, MIP-1α, MIP-2α, MIP-3α, and VEGF from diabetic compared to nondiabetic mice. Application of PG20N or AGRP and MC5 and MC1 antagonist, respectively, augmented the release of cytokines, while the agonists BMS-470539 and PG-901 almost restored normal pattern of these mediators back to nondiabetic values. Similar changes were quantified with respect to Ki-67 staining. Finally, application of MC3-MC4 agonist/antagonists resulted to be inactive with respect to all parameters under assessment.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Diabetic Retinopathy/drug therapy , Diabetic Retinopathy/metabolism , Receptor, Melanocortin, Type 1/metabolism , Receptors, Melanocortin/metabolism , Retina/drug effects , Retina/pathology , Animals , Chemokine CCL20/metabolism , Chemokine CCL3/metabolism , Chemokine CXCL2/metabolism , Diabetes Mellitus, Experimental/drug therapy , Diabetic Retinopathy/pathology , Imidazoles/pharmacology , Interleukin-1alpha/metabolism , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Mice , Peptides, Cyclic/pharmacology , Vascular Endothelial Growth Factor A/metabolism
3.
J Diabetes Res ; 2016: 5281267, 2016.
Article in English | MEDLINE | ID: mdl-26839893

ABSTRACT

This study investigated the effects of the new aldose reductase inhibitor benzofuroxane derivative 5(6)-(benzo[d]thiazol-2-ylmethoxy)benzofuroxane (BF-5m) on the prolongation of cardiac QT interval and increase of coronary perfusion pressure (CPP) in isolated, high glucose (33.3 mM D-glucose) perfused rat hearts. BF-5m was dissolved in the Krebs solution at a final concentration of 0.01 µM, 0.05 µM, and 0.1 µM. 33.3 mM D-glucose caused a prolongation of the QT interval and increase of CPP up to values of 190 ± 12 ms and 110 ± 8 mmHg with respect to the values of hearts perfused with standard Krebs solution (11.1 mM D-glucose). The QT prolongation was reduced by 10%, 32%, and 41%, respectively, for the concentration of BF-5m 0.01 µM, 0.05 µM, and 0.1 µM. Similarly, the CPP was reduced by 20% for BF-5m 0.05 µM and by 32% for BF-5m 0.1 µM. BF-5m also increased the expression levels of sirtuin 1, MnSOD, eNOS, and FOXO-1, into the heart. The beneficial actions of BF-5m were partly abolished by the pretreatment of the rats with the inhibitor of the sirtuin 1 activity EX527 (10 mg/kg/day/7 days i.p.) prior to perfusion of the hearts with high glucose + BF-5m (0.1 µM). Therefore, BF-5m supplies cardioprotection from the high glucose induced QT prolongation and increase of CPP.


Subject(s)
Aldehyde Reductase/antagonists & inhibitors , Benzofurans/pharmacology , Blood Pressure/drug effects , Coronary Circulation/drug effects , Diabetic Cardiomyopathies/prevention & control , Enzyme Inhibitors/pharmacology , Glucose/toxicity , Heart Rate/drug effects , Heart/drug effects , Myocardium/enzymology , Aldehyde Reductase/metabolism , Animals , Cardiotoxicity , Diabetic Cardiomyopathies/enzymology , Diabetic Cardiomyopathies/physiopathology , Forkhead Transcription Factors/metabolism , Heart/physiopathology , Histone Deacetylase Inhibitors/pharmacology , Isolated Heart Preparation , Male , Nerve Tissue Proteins/metabolism , Rats, Sprague-Dawley , Sirtuin 1/antagonists & inhibitors , Sirtuin 1/metabolism , Superoxide Dismutase/metabolism
4.
Oxid Med Cell Longev ; 2015: 190640, 2015.
Article in English | MEDLINE | ID: mdl-26265981

ABSTRACT

Rats receiving daily intraperitoneal administration of O2 and running on a treadmill covered an average distance of 482.8 ± 21.8 m/week as calculated during 5-week observation. This distance was increased in rats receiving daily intraperitoneal administration of an oxygen/O3 mixture at a dose of 100; 150; and 300 µg/kg with the maximum increase being +34.5% at 300 µg/kg and still present after stopping the administration of oxygen/O3. Oxygen/O3 decreased the mean arterial blood pressure (-13%), the heart rate (-6%), the gastrocnemius and cardiac hypertrophy, and fibrosis and reduced by 49% the left ventricular mass and relative wall thickness measurements. Systolic and diastolic functions were improved in exercised oxygen/O3 rats compared to O2 rats. Oxygen/O3 treatment led to higher MPI index starting from the dose of 150 µg/kg (p < 0.05) and more effective (+14%) at a dose of 300 µg/kg oxygen/O3. Oxygen/O3 dose-dependently increased the expression of the antioxidant enzymes Mn-SOD and GPx1 and of eNOS compared to the exercised O2 rats. The same doses resulted in decrease of LDH levels, CPK, TnI, and nitrotyrosine concentration in the heart and gastrocnemius tissues, arguing a beneficial effect of the ozone molecule against the fatigue induced by a prolonged high intensity exercise.


Subject(s)
Muscle Fatigue/drug effects , Oxygen/pharmacology , Physical Conditioning, Animal , Animals , Blood Pressure/drug effects , Creatine Kinase/metabolism , Fibrosis/prevention & control , Glutathione Peroxidase/metabolism , Heart Rate/drug effects , Hemodynamics/drug effects , Hypertrophy/prevention & control , L-Lactate Dehydrogenase/metabolism , Male , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Nitric Oxide Synthase Type III/metabolism , Oxygen/administration & dosage , Ozone/administration & dosage , Ozone/pharmacology , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/metabolism , Troponin I/metabolism
5.
Mediators Inflamm ; 2015: 126408, 2015.
Article in English | MEDLINE | ID: mdl-26180376

ABSTRACT

Rat endotoxin-induced uveitis (EIU) is a well-established model of human uveitis. In this model, intravitreal injection of resolvin D1 (RvD1, 10-100-1000 ng/kg) 1 hour after subcutaneous treatment of Sprague-Dawley rats with lipopolysaccharide (LPS, 200 µg/rat) significantly prevented the development of uveitis into the eye. RvD1 dose-dependently increased the expression of sirtuin-1 (SIRT1) within the eye, while it decreased the expression of acetyl-p53 and acetyl-FOXO1. These effects were accompanied by local downregulation of some microRNAs related to the expression and activity of SIRT1. These were miR-195-5p, miR-200a-3p, miR-34a-5p, and miR-145-5p. An increase of manganese superoxide dismutase and decrease of caspase 3 were evident after RvD1 treatment. In another set of experiments, the protective effects of RvD1 (1000 ng/kg) were partly abolished by the pretreatment of the rats with EX527 (10 mg/kg/day, i.p.), a specific inhibitor of SIRT1 activity, for 7 days prior to the induction of EIU in rats. Similarly, the effects of RvD1 (1000 ng/kg) on the SIRT1 protein expression were abolished by Boc2, N-t-butoxycarbonyl-PLPLP, a specific formyl-peptide receptor type 2/lipoxin A receptor antagonist. Therefore, an interplay of the SIRT1 activity on the RvD1 mediated resolution of EIU is argued.


Subject(s)
Docosahexaenoic Acids/pharmacology , Sirtuin 1/physiology , Uveitis/prevention & control , Animals , Caspase 3/analysis , Endotoxins/toxicity , Forkhead Transcription Factors/physiology , Intravitreal Injections , Nerve Tissue Proteins/physiology , Rats , Rats, Sprague-Dawley , Sirtuin 1/antagonists & inhibitors , Superoxide Dismutase/analysis , Tumor Suppressor Protein p53/physiology
6.
Mediators Inflamm ; 2015: 149381, 2015.
Article in English | MEDLINE | ID: mdl-25684860

ABSTRACT

This study investigated the protective effects of intravitreal Resolvin D1 (RvD1) against LPS-induced rat endotoxic uveitis (EIU). RvD1 was administered into the right eye at a single injection of 5 µL volume containing 10-100-1000 ng/kg RvD1 1 h post-LPS injection (200 µg, Salmonella minnesota) into thefootpad of Sprague-Dawley rats. 24 h later, the eye was enucleated and examined for clinical, biochemical, and immunohistochemical evaluations. RvD1 significantly and dose-dependently decreased the clinical score attributed to EIU, starting from the dose of 10 ng/kg and further decreased by 100 and 1000 ng/kg. These effects were accompanied by changes in four important determinants of the immune-inflammatory response within the eye: (i) the B and T lymphocytes, (ii) the miRNAs pattern, (iii) the ubiquitin-proteasome system (UPS), and (iv) the M1/M2 macrophage phenotype. LPS+RvD1 treated rats showed reduced presence of B and T lymphocytes and upregulation of miR-200c-3p, miR 203a-3p, miR 29b-3p, and miR 21-5p into the eye compared to the LPS alone. This was paralleled by decreases of the ubiquitin, 20S and 26S proteasome subunits, reduced presence of macrophage M1, and increased presence of macrophage M2 in the ocular tissues. Accordingly, the levels of the cytokine TNF-α, the chemokines MIP1-α and NF-κB were reduced.


Subject(s)
Docosahexaenoic Acids/therapeutic use , Lymphocytes/metabolism , Macrophages/metabolism , Proteasome Endopeptidase Complex/metabolism , Ubiquitin/metabolism , Uveitis/prevention & control , Animals , Docosahexaenoic Acids/administration & dosage , Enzyme-Linked Immunosorbent Assay , Immunohistochemistry , Intravitreal Injections , Lymphocytes/drug effects , Macrophages/drug effects , Male , Proteasome Endopeptidase Complex/drug effects , Rats , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction
7.
Mediators Inflamm ; 2014: 857958, 2014.
Article in English | MEDLINE | ID: mdl-25435715

ABSTRACT

The study investigated the effects of the aldose reductase (AR) inhibitor benzofuroxane derivative 5(6)-(benzo[d]thiazol-2-ylmethoxy) benzofuroxane (herein referred to as BF-5m) on the biochemical and tissue alterations induced by endotoxic uveitis in rats. BF-5m has been administered directly into the vitreous, in order to assess the expression and levels of (i) inflammatory markers such as the ocular ubiquitin-proteasome system, NF-κB, TNF-α, and MCP-1; (ii) prooxidant and antioxidant markers such as nitrotyrosine, manganese superoxide dismutase (MnSOD), and glutathione peroxidase (GPX); (iii) apoptotic/antiapoptotic factors caspases and Bcl-xl; (iv) markers of endothelial progenitor cells (EPCs) recruitment such as CD34 and CD117. 5 µL of BF-5m (0.01; 0.05; and 0.1 µM) into the right eye decreased in a dose-dependent manner the LPS-induced inflammation of the eye, reporting a clinical score 1. It reduced the ocular levels of ubiquitin, 20S and 26S proteasome subunits, NF-κB subunits, TNF-α, MCP-1, and nitrotyrosine. BF-5m ameliorated LPS-induced decrease in levels of MnSOD and GPX. Antiapoptotic effects were seen from BF-5m by monitoring the expression of Bcl-xl, an antiapoptotic protein. Similarly, BF-5m increased recruitment of the EPCs within the eye, as evidenced by CD34 and CD117 antibodies.


Subject(s)
Aldehyde Reductase/antagonists & inhibitors , Benzofurans/pharmacology , Enzyme Inhibitors/pharmacology , Uveitis/drug therapy , Animals , Antioxidants/metabolism , Apoptosis/drug effects , Benzofurans/chemistry , Disease Models, Animal , Enzyme Inhibitors/chemistry , Eye/enzymology , Inflammation Mediators/metabolism , Lipopolysaccharides/toxicity , Male , Oxidative Stress/drug effects , Proteasome Endopeptidase Complex/metabolism , Rats , Rats, Sprague-Dawley , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Ubiquitin/metabolism , Uveitis/metabolism , Uveitis/pathology
8.
Mediators Inflamm ; 2014: 972761, 2014.
Article in English | MEDLINE | ID: mdl-25110402

ABSTRACT

This study investigated the involvement of proteasome and macrophages M2 in the protection afforded by telmisartan against the acute myocardial infarction in Zucker diabetic fatty (ZDF) rats with metabolic syndrome. ZDF rats were treated for three weeks with telmisartan at doses of 7 and 12 mg/kg/day. After treatment, rats were subjected to a 25 min occlusion of the left descending coronary artery followed by 2 h reperfusion (I/R). At the end of the I/R period, biochemical, immunohistochemical, and echocardiographic evaluations were done. Telmisartan treatment (7 mg/kg and 12 mg/kg) reduced the myocardial infarct size, the expression of proteasome subunits 20S and 26S, and the protein ubiquitin within the heart. The compound has led to an increased M2 macrophage phenotype within the cardiac specimens and a modification of the cardiac cytokine and chemokine profile. This was functionally translated in improved cardiac performance as evidenced by echography after 2 h reperfusion. 7 mg/kg/day telmisartan was sufficient to improve the left ventricular ejection fraction LVEF of the rat heart recorded after I/R (e.g., vehicle 38 ± 2.2%; telmisartan 54 ± 2.7%) and was sufficient to improve the diastolic function and the myocardial performance index up to values of 0.6 ± 0.01 measured after I/R.


Subject(s)
Benzimidazoles/therapeutic use , Benzoates/therapeutic use , Macrophages/metabolism , Metabolic Syndrome/drug therapy , Myocardial Infarction/drug therapy , Proteasome Endopeptidase Complex/metabolism , Animals , Metabolic Syndrome/immunology , Myocardial Infarction/immunology , Rats , Rats, Zucker , Telmisartan
9.
Environ Pollut ; 171: 162-7, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22922455

ABSTRACT

In the recent literature there has been an increased interest in the effects of particulate matter on the respiratory tract. The objective of this study was to use an in vitro model of type II lung epithelium (A549) to evaluate the cell ability to take up sub-micron PM(1.0) particles (PM(1.0)), Parietaria officinalis (ALL), and PM(1.0) + ALL together. Morphological analysis performed by Transmission Electron Microscope (TEM) showed that PM and ALL interacted with the cell surface, then penetrating into the cytoplasm. Each single treatment was able to point out a specific change in the morphology. The cells treated appear healthy and not apoptotic. The main effect was the increase of: multilamellar bodies, lysosomal enzymes, microvilli, and presence of vesicle/vacuoles containing particles. These observations demonstrate morphological and functional alterations related to the PM(1.0) and P. officinalis and confirm the induction of the inflammatory response in lung cells exposed to the inhalable particles.


Subject(s)
Air Pollutants/toxicity , Allergens/toxicity , Lung/drug effects , Particulate Matter/toxicity , Pollen/toxicity , Vehicle Emissions/toxicity , Cell Line , Epithelial Cells/drug effects , Epithelial Cells/pathology , Humans , Lung/pathology
10.
Environ Pollut ; 161: 64-9, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22230069

ABSTRACT

Asthma is currently defined as a chronic inflammatory disease of the airway. Several evidence indicate that vehicle emissions in cities is correlated with the allergic respiratory diseases. In the present study, we evaluated in the A549 cells the production and release of IL-4, IL-5 and IL-13 after treatment with sub-micron PM(1.0) particles (PM(1.0)), Parietaria officinalis (ALL), and PM(1.0) + ALL together. Our data demonstrated that PM(1.0) + ALL together exhibited the greatest capacity to induce A549 cells to enhance the expression of IL-4 and IL-5 compared with the only PM(1.0) or ALL treatment. Interestingly, IL-13 that is necessary for allergen-induced airway hyper responsiveness, is increased in cells treated with PM(1.0) + ALL together, but is higher expressed when the cells are treated only with the allergen. Our data support the hypothesis that the urban environment damage the acinar lung units and activates cells of the immune system.


Subject(s)
Air Pollutants/toxicity , Allergens/toxicity , Lung/immunology , Vehicle Emissions/toxicity , Cell Line , Epithelial Cells/drug effects , Epithelial Cells/immunology , Epithelial Cells/metabolism , Humans , Lung/drug effects , Lung/metabolism , Particle Size , Particulate Matter/toxicity , Pollen/toxicity
11.
Diabetes Obes Metab ; 14(4): 320-8, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22050607

ABSTRACT

AIM: This study investigated whether telmisartan, a selective angiotensin type 1 (AT1) receptor antagonist and gamma peroxisome proliferator-activated receptor (PPAR-γ) partial agonist, reduces myocardial ischaemia/reperfusion (I/R) injury in an experimental model of metabolic syndrome. METHODS: Zucker Diabetic Fatty (ZDF) rats were treated for 3 weeks with telmisartan at doses of 2, 7 and 12 mg/kg/day. After treatment, rats were subjected to a 25-min occlusion of the left descending coronary artery followed by 2-h reperfusion (I/R). RESULTS: Telmisartan reduced the extension of the infarct size in a dose-dependent fashion and decreased the levels of plasma troponin I, a specific marker of myocardial damage. Telmisartan also caused a dose-dependent increase in adiponectin both in plasma and cardiac tissue of infarcted ZDF rats. These levels were minimally increased (p < 0.05 vs. vehicle) by telmisartan 7 mg/kg/day and reached the maximum values with the highest dose of 12 mg/kg/day (p < 0.01 vs. vehicle). In contrast, within the infarcted tissue telmisartan decreased the expression of markers of inflammation such as the transcription factor NF-κB, the toll-like receptors TLR2 and TLR4 as well as TNF-α cytokine. Nitrosative stress was maximal in vehicle-treated infarcted hearts as evidenced by increased expression of iNOS, which was almost abolished after treatement with telmisartan. CONCLUSIONS: Treatment of ZDF rats for 3 weeks with telmisartan, a dual angiotensin II receptor antagonist and partial PPAR-γ receptor agonist, resulted in a significant reduction of myocardial damage induced by I/R and was associated with increased adiponectin and a decrease in inflammatory markers.


Subject(s)
Adiponectin/metabolism , Angiotensin II Type 1 Receptor Blockers/pharmacology , Benzimidazoles/pharmacology , Benzoates/pharmacology , Cardiotonic Agents/pharmacology , Metabolic Syndrome/drug therapy , Myocardial Reperfusion Injury/drug therapy , PPAR gamma/agonists , PPAR gamma/drug effects , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Disease Models, Animal , Heart/drug effects , Heart/physiopathology , Immunohistochemistry , Metabolic Syndrome/metabolism , Myocardial Reperfusion Injury/metabolism , NF-kappa B/drug effects , NF-kappa B/metabolism , PPAR gamma/blood , Rats , Rats, Zucker , Telmisartan , Troponin I/blood , Troponin I/drug effects , Tumor Necrosis Factor-alpha/drug effects , Tumor Necrosis Factor-alpha/metabolism
12.
Int J Immunopathol Pharmacol ; 24(4): 1125-9, 2011.
Article in English | MEDLINE | ID: mdl-22230423

ABSTRACT

Breast involvement is a rare event in SLE patients. The most frequent presentation is lupus panniculitis with skin erythema, tenderness, and parenchymal nodules. However, when breast masses are detected in SLE patients without significant superficial inflammation, it is mandatory to rule out breast carcinoma. Here, we report the case of a 47-year-old woman with an 18-year-long history of SLE, who presented with a suspicious breast mass. Since surgical trauma has been reported to be able to exacerbate breast inflammation in lupus mastitis, an ultrasound-guided minimally invasive Mammotome biopsy was performed to obtain tissue samples for histological and immunohistochemical examinations. Histology was consistent with lupus mastitis. The patient was already on mycophenolate mofetil and hydroxychloroquine. At the latest follow-up visit 6 years later, no progression of the breast lesion was observed.


Subject(s)
Lupus Erythematosus, Systemic/complications , Mastitis/diagnosis , Biopsy , Breast Neoplasms/diagnosis , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Immunosuppressive Agents/therapeutic use , Lupus Erythematosus, Systemic/drug therapy , Mastitis/etiology , Middle Aged , Predictive Value of Tests , Recurrence , Ultrasonography, Mammary
14.
Inflamm Res ; 57(10): 445-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18827966

ABSTRACT

OBJECTIVE AND DESIGN: We tested here the effects of acute administration of an oxygen/ozone (O3) mixture on the myocardial tissue damage following an ischemic event. MATERIAL OR SUBJECTS: The study was done in Sprague-Dawley rats subjected to acute myocardial ischemia/reperfusion (I/R). TREATMENT: 100; 150; and 300 microg/kg oxygen/O3 mixture were insufflated intraperitoneally 1 h prior to I/R. METHODS: Myocardial infarct size measurement and immunhistochemistry or ELISA for nitrotyrosine, CD68, CD8,CD4 and caspase-3 were done. RESULTS: I/R produced a marked damage in the rat left ventricle with an infarct size as percentage of the area at risk (IS/ AR) of approximately 45 +/- 4% . Rats insufflated with a oxygen/O3 mixture showed a significant 2-h cardio-protection (e. g. infarct size over area at risk for the dose of 300 microg/kg was approximately 30 +/- 3%,) as compared with control rats (P <0.01). This effect was paralleled by a decrease in tissue levels of immunostaining for biomarkers of nitrosative stress (nitrotyrosine), inflammation (CD68) and immunity response (CD8 and CD4) between heart tissues from infarcted rats and infarcted O3 treated rats. CONCLUSIONS: These data indicate that the tissue and biochemical damages associated with myocardial ischemia/reperfusion can be counteracted by an acute O3 pretreatment.


Subject(s)
Heart/drug effects , Myocardial Infarction/prevention & control , Myocardial Ischemia/drug therapy , Myocardial Reperfusion Injury/prevention & control , Oxygen , Ozone , Animals , Humans , Male , Myocardial Infarction/drug therapy , Myocardial Infarction/pathology , Oxygen/pharmacology , Oxygen/therapeutic use , Ozone/pharmacology , Ozone/therapeutic use , Random Allocation , Rats , Rats, Sprague-Dawley
15.
Cancer Invest ; 26(3): 250-5, 2008.
Article in English | MEDLINE | ID: mdl-18317965

ABSTRACT

Vascular endothelial growth factor (VEGF) is a potent stimulator of angiogenesis, associated with unfavorable clinical characteristics in breast cancer. The aim of this study was to evaluate different angiogenic markers in endocrine-positive breast cancer patients. The authors analyzed serum and tumor samples from 71 patients with endocrine-positive operable primary breast cancer to determine the expression and the possible relationship between circulating serum VEGF levels, tumor VEGF expression, microvessel density (MVD), and other immunohistochemical parameters. Basal VEGF serum levels were significantly higher in breast cancer patients than in healthy controls. A significant correlation was observed between basal VEGF serum concentrations, microvessel density (p = 0.01) and p53 status (p = 0.004). Intratumoral VEGF expression was significantly associated with neoplastic embolization (p = 0.041) and circulating VEGF levels (p = 0.047). The results confirm that in primary endocrine-positive breast cancer serum VEGF levels are elevated and show a positive relationship with tumor VEGF and p53 overexpression.


Subject(s)
Breast Neoplasms/blood , Tumor Suppressor Protein p53/biosynthesis , Vascular Endothelial Growth Factor A/blood , Vascular Endothelial Growth Factor A/metabolism , Adult , Aged , Aged, 80 and over , Breast Neoplasms/blood supply , Breast Neoplasms/pathology , Disease Progression , Female , Humans , Immunohistochemistry , Middle Aged , Neoplastic Cells, Circulating/pathology , Neovascularization, Pathologic/metabolism , Receptors, Estrogen/metabolism
16.
Int J Immunopathol Pharmacol ; 20(2): 401-3, 2007.
Article in English | MEDLINE | ID: mdl-17624254

ABSTRACT

Primary testicular lymphoma is an uncommon testicular tumour. We present a case of a primary non-Hodgkin lymphoma of the testis, describing its clinical and pathological features and discussing our treatment strategy. A 68-year-old man showed a firm erythematous testicular mass within the right emiscrotum. Subsequent ultrasonography demonstrated a right inferior pole testicular mass with disomogenously hypoecogenic. The patient was submitted to inguinal orchidectomy. Light microscopy demonstrated the classic appearance of a diffuse large B-cell lymphoma. The immunohistochemical study showed tumour cells intensively positive for CD45, Ki67 and CD20. No evidence of extra-testicular involvement by lymphoma was found. At 6 months, a TC-PET showed a clinical relapse in lung and abdominal lymphonodes, while clinical examination demonstrated a single, indolent and erythematous nodule in the left foot. The histologic analysis confirmed diagnosis of CD-20 positive B-cell lymphoma. The patient was treated with an anti-CD 20 monoclonal antibody (rituximab) alone every 3 weeks. After 3 months a complete response was observed in all sites of disease. The patient was free from disease at 12 months follow-up.


Subject(s)
Antibodies, Monoclonal/pharmacology , Antineoplastic Agents/pharmacology , Lymphoma, B-Cell/drug therapy , Lymphoma, Large B-Cell, Diffuse/drug therapy , Testicular Neoplasms/drug therapy , Aged , Antibodies, Monoclonal, Murine-Derived , Humans , Lymphoma, B-Cell/pathology , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Rituximab , Testicular Neoplasms/pathology , Testicular Neoplasms/secondary
17.
Respir Med ; 101(6): 1155-62, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17280825

ABSTRACT

Atmospheric particulate matter (PM), an ingredient of urban pollution matter, is a mixture of solid and liquid particles differing in origin, dimension and composition. There is big concern about inhaled PM in urban areas, especially due to its adverse effects on the respiratory system. Diesel exhaust particulate (DEP), which constitutes the major part of PM, is characterized by a carbonic mixture composed of approximately 18,000 different high-molecular-weight organic compounds. Diesel engines release 10 times the amount of NO(2) aldehydes and breathable PM compared to unleaded gasoline engines and more than 100 times that produced by catalysed gasoline engines; these data gain great significance when taken into account the fact that diesel-powered vehicles are becoming more and more popular. DEP polyaromatic hydrocarbons (PAH), once deposited on airways mucous surfaces easily pass through epithelial cells (ECs) membranes, bind themselves to cytosolic receptors and then affect cell growth and differentiation. Human lung epithelial cells and macrophages engulf DEP, this resulting in increased proinflammatory cytokines release (IL-6, IL-8 and GM-CSF). We investigated the biological effects of DEP-PM on the human lung EC line A549. Light microscopy analysis suggested the presence of cell wall alterations, and provided evidence of PM internalization and cytoplasmic vacuolization. Following PM stimulation, nuclei also were seen undergo clear gross morphological modifications. Immunocytochemistry was used to detect intracytoplasmic IL-6 and IL-8 expression.


Subject(s)
Air Pollutants/pharmacology , Respiratory Mucosa/drug effects , Vehicle Emissions/toxicity , Air Pollutants/analysis , Cell Size/drug effects , Cytoplasm/immunology , Environmental Monitoring/methods , Epithelial Cells/drug effects , Epithelial Cells/immunology , Epithelial Cells/pathology , Humans , Interleukin-6/metabolism , Interleukin-8/metabolism , Particle Size , Particulate Matter/analysis , Particulate Matter/pharmacology , Respiratory Mucosa/immunology , Respiratory Mucosa/pathology , Tumor Cells, Cultured , Vehicle Emissions/analysis
18.
Minerva Stomatol ; 55(9): 483-92, 2006 Sep.
Article in English, Italian | MEDLINE | ID: mdl-17146427

ABSTRACT

AIM: Pleomorphic adenomas of salivary glands are benign lesions which may sometimes relapse even after complete surgical removal. This risk has led to the search for methods to provide predictive data on the biological behaviour of such neoplasia. The authors intend to evaluate the degree of cellular aggression of these tumours by finding prognostic data using the antigens involved in cellular proliferative activity. Therefore they have chosen for this study: p27kip1, cyclin B1 and Cyclin D3. METHODS: Seventeen mixed tumours, 2 of them relapsed, underwent the direct immunohystochemical PAP technique for the determination of antigens p27kip1, cyclins B1 and D3 of the tissue. RESULTS: The results obtained show that the verification of these markers may reveal a potential risk of biological deviation and that their expression is independent of the degree of cellularity in neoplasias. CONCLUSIONS: On the basis of the results, the conclusion is drawn that there is no relation between the expressivity of the mentioned antigens and histological characters of pleomorphic adenomas.


Subject(s)
Adenoma, Pleomorphic/chemistry , Biomarkers, Tumor/analysis , Cyclin B/analysis , Cyclin-Dependent Kinase Inhibitor p27/analysis , Cyclins/analysis , Salivary Gland Neoplasms/chemistry , Adenoma, Pleomorphic/pathology , Adolescent , Adult , Aged , Biomarkers, Tumor/immunology , Cyclin B/immunology , Cyclin B1 , Cyclin D3 , Cyclin-Dependent Kinase Inhibitor p27/immunology , Cyclins/immunology , Humans , Immunohistochemistry/methods , Middle Aged , Prognosis , Salivary Gland Neoplasms/pathology
19.
Clin Neuropathol ; 22(4): 187-92, 2003.
Article in English | MEDLINE | ID: mdl-12908755

ABSTRACT

OBJECTIVE: Histological analysis has limited value to predict the biological behavior of meningiomas. In this study, we investigated the utility of indicators of cell proliferation in the evaluation of histologically benign meningiomas. MATERIALS AND METHODS: For this purpose, 50 meningothelial meningiomas, 50 atypical meningiomas and 8 primary benign meningiomas with their recurrences were studied. For each case the Ki67 labeling index (LI), DNA ploidy and AgNOR were evaluated and the results quantitatively processed and assessed by computerized image analyzer. RESULTS: The Ki67 labelling showed a low index (11.3%) in typical meningiomas and primary meningiomas (13.6%). In contrast, it was higher in atypical (26.6%) and recurrent meningiomas (28%). Similar results were obtained for the AgNOR granule count which showed that typical and primary meningiomas had mean 1.51 - 1.49, whereas recurring meningiomas and atypical meningiomas had mean values of 1.92 and 1.98, respectively. DNA ploidy revealed in the hyperpolyploid region between 4c - 16c: 7.02% of the nuclei in primary meningiomas, 17.98% of the nuclei in recurring meningiomas and 24.63% of the nuclei in atypical meningiomas. CONCLUSION: Our results suggest that evaluation of cell proliferation using Ki67 LI, DNA ploidy and AgNOr, integrated with standard histopathology, can provide better information for a correct grading of meningiomas.


Subject(s)
DNA, Neoplasm/analysis , Ki-67 Antigen/analysis , Meningeal Neoplasms/pathology , Meningioma/pathology , Nucleolus Organizer Region/pathology , Polyploidy , Rosaniline Dyes , Cell Division/physiology , Coloring Agents/analysis , Humans , Immunohistochemistry , Meningeal Neoplasms/chemistry , Meningeal Neoplasms/genetics , Meningioma/chemistry , Meningioma/genetics , Mitotic Index , Neoplasm Recurrence, Local/chemistry , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/pathology , Predictive Value of Tests , Silver/analysis
20.
Eur J Cardiothorac Surg ; 21(4): 675-82, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11932167

ABSTRACT

OBJECTIVE: To investigate whether and how the severity of medial degeneration (MD) lesions varies along the circumference of the dilated intrapericardial aorta. METHODS: Two groups of aortic wall specimens, respectively harvested 1cm distal to the non-coronary (NC) sinus (right postero-lateral wall) and to the right coronary sinus (anterior wall) in 22 patients undergoing surgery for dilatation of the intrapericardial aorta associated with aortic valve disease, were separately sent for pathology, morphometry and ultrastructural examination. MD lesions found at histology were classified into three degrees of severity. MD mean degree and morphometric findings in postero-lateral ('NC') and anterior ('coronary') specimens were compared by paired t-test. Correlation between degree of aortic dilatation at echocardiography and severity of MD was assessed separately for each of the two groups of specimens. After the preliminary results of the morphological study, we decided to send the specimens for biochemical investigation of protein electrophoretic patterns. This was performed in the last seven patients of this series. RESULTS: At histology, MD was found in all cases. A higher mean MD degree was found in the NC group (2.59+/-0.50 versus 1.59+/-0.67 in the coronary group; P<0.001). At morphometry, normal smooth muscle cells in the NC specimens were significantly reduced (P=0.012) and the length (P=0.011) and number (P=0.015) of elastic fibres reduced and increased, respectively. Correlation between aortic ratio and MD degree was significant in the NC specimens (P<0.001), not in the coronary ones (P=0.227). Quantitative differences between coronary and NC proteins from the same patient and between coronary proteins from different patients were found at electrophoresis. However, at this stage of the study, the sample was too small to allow for the identification of proteins involved in those differences. CONCLUSIONS: MD lesions in dilated intrapericardial aorta are more severe in the right postero-lateral wall area, likely due to haemodynamic stress asymmetry.


Subject(s)
Aorta/pathology , Dilatation, Pathologic/diagnosis , Adult , Aged , Aorta/diagnostic imaging , Aortic Valve/diagnostic imaging , Aortic Valve/pathology , Aortic Valve Insufficiency/diagnosis , Aortic Valve Stenosis/diagnosis , Apoptosis , Coronary Vessels/cytology , Coronary Vessels/ultrastructure , Echocardiography, Doppler , Electrophoresis, Gel, Two-Dimensional , Female , Humans , Male , Middle Aged , Muscle, Smooth, Vascular/cytology , Muscle, Smooth, Vascular/metabolism , Reproducibility of Results , Severity of Illness Index , Statistics as Topic
SELECTION OF CITATIONS
SEARCH DETAIL
...